Pages that link to "Q34648366"
Jump to navigation
Jump to search
The following pages link to Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis (Q34648366):
Displaying 50 items.
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Q22676705) (← links)
- Targeting inflammation in diabetes: Newer therapeutic options (Q26852726) (← links)
- Comparative effectiveness research with administrative health data in rheumatoid arthritis (Q31077662) (← links)
- Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus (Q33422958) (← links)
- Metabolic abnormalities and cardiovascular risk factors in children with myositis (Q33602858) (← links)
- Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients (Q33650548) (← links)
- Management of cardiovascular complications in systemic lupus erythematosus (Q33730536) (← links)
- Effect of atorvastatin and hydroxychloroquine combination on blood glucose in alloxan-induced diabetic rats (Q33819280) (← links)
- Risk of rheumatoid arthritis in patients with type 2 diabetes: a nationwide population-based case-control study (Q33838440) (← links)
- Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment (Q33943374) (← links)
- Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus (Q34162739) (← links)
- Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis (Q34348857) (← links)
- Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases (Q34354276) (← links)
- A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role (Q34389286) (← links)
- Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease (Q34459100) (← links)
- DMPPQA, a novel angiogenesis inhibitor, induces apoptosis in human colon cancer HCT-116 cells and HUVECs (Q35057273) (← links)
- Advances in the Medical Treatment of Rheumatoid Arthritis (Q35102474) (← links)
- Hydroxychloroquine as a glucose lowering drug (Q35519392) (← links)
- Therapeutic approaches to target inflammation in type 2 diabetes (Q35581498) (← links)
- Effect of hydroxychloroquine on insulin sensitivity and lipid parameters in rheumatoid arthritis patients without diabetes mellitus: a randomized, blinded crossover trial (Q35742831) (← links)
- Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial (Q36073241) (← links)
- Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence (Q36240425) (← links)
- Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals (Q36246086) (← links)
- Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus (Q36277899) (← links)
- Autoimmune thyroid disease in rheumatoid arthritis: a global perspective (Q36421188) (← links)
- Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis (Q36464352) (← links)
- Integration of cellular bioenergetics with mitochondrial quality control and autophagy (Q36675381) (← links)
- Chloroquine increases phosphorylation of AMPK and Akt in myotubes. (Q36754793) (← links)
- Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients (Q36877859) (← links)
- Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients (Q36906782) (← links)
- Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion (Q37058791) (← links)
- Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid Arthritis (Q37169479) (← links)
- The effect of hydroxychloroquine on glucose control and insulin resistance in the prediabetes condition (Q37261219) (← links)
- Management of cardiovascular disease risk in chronic inflammatory disorders (Q37428743) (← links)
- Premature vascular damage in systemic lupus erythematosus: an imbalance of damage and repair? (Q37549027) (← links)
- Rheumatoid arthritis is associated with reduced adiposity but not with unfavorable major cardiovascular risk factor profiles and enhanced carotid atherosclerosis in black Africans from a developing population: a cross-sectional study (Q37691220) (← links)
- Drug-induced hypoglycaemia: an update (Q37799813) (← links)
- Autophagic degradation of mitochondria in white adipose tissue differentiation (Q37815217) (← links)
- Hydroxychloroquine: from malaria to autoimmunity (Q37827403) (← links)
- Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease (Q37859679) (← links)
- Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. (Q37883018) (← links)
- Risk factors for cardiovascular disease in rheumatoid arthritis (Q37976283) (← links)
- Rheumatoid arthritis and cardiovascular disease (Q38149252) (← links)
- Autophagy in adipose tissue and the beta cell: implications for obesity and diabetes (Q38209287) (← links)
- Cooling down inflammation in type 2 diabetes: how strong is the evidence for cardiometabolic benefit? (Q38845570) (← links)
- Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes (Q38927961) (← links)
- Hydroxychloroquine's Efficacy as an Antiplatelet Agent Study in Healthy Volunteers: A Proof of Concept Study (Q39144641) (← links)
- The lysosome among targets of metformin: new anti-inflammatory uses for an old drug? (Q39882878) (← links)
- Hydroxychloroquine hindering of diabetic isletopathy carries its signature on the inflammatory cytokines. (Q41915768) (← links)
- Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study (Q41918910) (← links)